Table of Contents

company-logo

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

TC Biopharm Dividend Announcement

• TC Biopharm does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on TC Biopharm dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

TC Biopharm Dividend History

TC Biopharm Dividend Yield

TC Biopharm current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing TC Biopharm stock? Use our calculator to estimate your expected dividend yield:

TC Biopharm Financial Ratios

P/E ratio-1.69
PEG ratio-0.02
P/B ratio14.61
ROE-442.56%
Payout ratio0.00%
Current ratio0.88
Quick ratio0.88
Cash Ratio0.21

TC Biopharm Dividend FAQ

Does TC Biopharm stock pay dividends?
TC Biopharm does not currently pay dividends to its shareholders.
Has TC Biopharm ever paid a dividend?
No, TC Biopharm has no a history of paying dividends to its shareholders. TC Biopharm is not known for its dividend payments.
Why doesn't TC Biopharm pay dividends?
There are several potential reasons why TC Biopharm would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will TC Biopharm ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While TC Biopharm has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is TC Biopharm a dividend aristocrat?
TC Biopharm is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is TC Biopharm a dividend king?
TC Biopharm is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is TC Biopharm a dividend stock?
No, TC Biopharm is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy TC Biopharm stocks?
To buy TC Biopharm you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy TC Biopharm stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.